BALHARA, MBBS, MD, DNB, MNAMS, Y. P. S. Time to include buprenorphine-naloxone combination in the WHO model list of essential medicines. Journal of Opioid Management, [S. l.], v. 9, n. 4, p. 237, 2013. DOI: 10.5055/jom.2013.0164. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/566. Acesso em: 22 nov. 2024.